StockPriceToday
ProFrac Holding Corp. (ACDC)
About ProFrac Holding Corp.
ProFrac Holding Corp. operates as a leading provider of hydraulic fracturing, proppant delivery, and related completion services to oil and gas companies across major North American shale basins. The company's operations make ACDC stock price highly sensitive to oil and gas drilling activity and commodity price fluctuations.
The company offers a comprehensive suite of pressure pumping services, including hydraulic fracturing, cementing, coiled tubing, and flowback services. ProFrac's modern fleet of equipment and focus on operational efficiency enable the company to serve major oil and gas operators while maintaining competitive positioning in the challenging oilfield services market.
ACDC stock price typically correlates with oil and gas industry activity levels, as increased drilling and completion activity drives demand for hydraulic fracturing services. The company's geographic diversification across multiple shale basins provides operational flexibility and helps mitigate regional market volatility.
ProFrac's investment in next-generation fracturing technology, including electric-powered equipment and emissions reduction initiatives, positions the company to capitalize on industry trends toward more sustainable and efficient completion operations. These technological advantages influence ACDC stock price by potentially improving margins and competitive positioning in the evolving oilfield services landscape.
ACDC Stock 12 Month Chart
Latest News for ACDC
ProFrac Holding Corp (PFHC) reported its financial results for the first quarter of 2026, revealing a significant earnings miss with an EPS of -0.4478 USD, compared to the forecasted -0.3793 USD. The ...
ProFrac missed EPS expectations by 18.06%. Revenue exceeded forecasts, driven by strong segment performances. Stock price dropped 6.59% post-earnings but shows slight recovery pre-market. Operational ...
Other Popular Stocks
MBX Biosciences Inc. (MBX) is a biotechnology company developing peptide and protein therapeutics for endocrine and metabolic diseases using innovative drug delivery technologies.
Contineum Therapeutics Inc. (CTNM) is a clinical-stage biopharmaceutical company focused on developing novel treatments for neurodegenerative diseases and related disorders.
Arcellx Inc. is a biotechnology company developing innovative immunotherapies for cancer treatment using advanced cell engineering technologies.